Radiodermatitis
Conditions
Interventions
This is a two-arm, triple-blind, randomized controlled clinical study. Experimental group: 38 patients with breast cancer and recommended radiotherapy treatment will receive a cream containing a blend
Sponsors
Instituto do Câncer do Ceará
Universidade Federal do Ceará
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years old; both sexes; diagnosis of breast cancer with indication of adjuvant radiotherapy treatment in the breast region; intact and continuous skin in the target region; first day of radiotherapy treatment (new cases); absence of previous history of radiotherapy in the same field/site of treatment; absence of previous treatment with chemotherapy, acceptance to participate in the research by signing the Informed Consent Form
Exclusion criteria
Exclusion criteria: Have hypersensitivity to one of the components of the research creams; patients with indication for electron radiotherapy; deficit in adhering to the research intervention and following the study guidelines
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to evaluate the effectiveness of creams used to prevent radiodermatitis and help prevent its progression. For this purpose, the following methods will be used: CTCAE Scale, in which the radiodermatitis found is expected to reach a maximum of grade 2; Skin analyzer pen, associated with the skin pH meter, to assess the level of hydration and functionality of the skin, expecting to find percentages of water between 40-60%, oil 16-22% and pH between 4.6-5.8 | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactLara de Moura
Instituto do Câncer do Ceará
Outcome results
None listed